Company Encyclopedia
View More
name
iSpecimen
ISPC.US
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types.
64.63 B
ISPC.USMarket value -Rank by Market Cap -/-

Financial Score

14/12/2025 Update
E
Health Care TechnologyIndustry
Industry Ranking43/44
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-296.20%E
    • Profit Margin-343.99%E
    • Gross Margin-91.94%E
  • Growth ScoreE
    • Revenue YoY-67.73%E
    • Net Profit YoY-21.10%D
    • Total Assets YoY-20.12%E
    • Net Assets YoY-34.83%E
  • Cash ScoreE
    • Cash Flow Margin-29.07%D
    • OCF YoY-67.73%E
  • Operating ScoreD
    • Turnover0.33D
  • Debt ScoreD
    • Gearing Ratio65.85%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pre-market hot trades in US stocks: iSpecimen pre-market down 4.76%; Robinhood pre-market down 3.00%

    iSpecimen pre-market down 4.76%; Robinhood pre-market down 3.00%; Direct Digital pre-market up 73.00%; Webuy Global pre-market up 44.30%; Republic Power pre-market up 39.51%

    Tracking Unusual Activity·
    US
    ISPC
    -6.50%
    US
    HOOD
    -3.14%
    Tracking Unusual Activity·
    US
    ISPC
    -6.50%
    US
    HOOD
    -3.14%

    iSpecimen Receives Nasdaq Notice for Noncompliance with Minimum Bid Price

    iSpecimen Inc. has received a notice from Nasdaq for noncompliance with the minimum bid price requirement of $1.00 per share. The company's stock has been below this threshold for 30 consecutive business days. iSpecimen has until May 18, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. The stock will continue to trade under the symbol "ISPC" as the company explores options to address the issue.

    Reuters·
    US
    ISPC
    -6.50%
    Reuters·
    US
    ISPC
    -6.50%

    iSpecimen Inc. Files Initial Statement of Beneficial Ownership for Director Lee Arphing

    iSpecimen Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, listing Lee Arphing as a Director with no securities currently beneficially owned. The filing can be accessed via EDGAR. This news brief was created by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    ISPC
    -6.50%
    Reuters·
    US
    ISPC
    -6.50%

    iSpecimen | 10-Q: FY2025 Q3 Revenue: USD 106.59 K

    LB filings·
    US
    ISPC
    -6.50%
    LB filings·
    US
    ISPC
    -6.50%

    iSpecimen Inc. Delays Quarterly Financial Report Filing

    iSpecimen Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the period ended September 30, 2025. The company is seeking a five-day extension under SEC Rule 12b-25 due to the delay.

    Reuters·
    US
    ISPC
    -6.50%
    Reuters·
    US
    ISPC
    -6.50%
    © 2025 Longbridge｜Disclaimer